AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $634,040 | +53.5% | 65,500 | +73.8% | 0.01% | +33.3% |
| Q1 2023 | $413,082 | +653.5% | 37,690 | +197.0% | 0.01% | +500.0% |
| Q4 2022 | $54,821 | -50.2% | 12,690 | -56.6% | 0.00% | 0.0% |
| Q3 2022 | $110,110 | -70.1% | 29,234 | -20.2% | 0.00% | -85.7% |
| Q2 2022 | $368,000 | -66.0% | 36,618 | -58.1% | 0.01% | -46.2% |
| Q1 2022 | $1,081,000 | -75.1% | 87,300 | -54.1% | 0.01% | -59.4% |
| Q4 2021 | $4,349,000 | +849.6% | 190,134 | +511.4% | 0.03% | +255.6% |
| Q3 2020 | $458,000 | -69.9% | 31,100 | -66.8% | 0.01% | -82.0% |
| Q2 2020 | $1,521,000 | +74.6% | 93,608 | +55.9% | 0.05% | +47.1% |
| Q1 2020 | $871,000 | -6.6% | 60,053 | +30.4% | 0.03% | +100.0% |
| Q4 2019 | $933,000 | – | 46,054 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |